Literature DB >> 27454938

High-salt diet induces outward remodelling of efferent arterioles in mice with reduced renal mass.

L Zhao1, Y Gao1, X Cao1, D Gao2, S Zhou1, S Zhang1, X Cai1,3, F Han4, C S Wilcox5, L Li5, E Y Lai1,5.   

Abstract

AIM: The glomerular filtration rate (GFR) falls progressively in chronic kidney disease (CKD) which is caused by a reduction in the number of functional nephrons. The dysfunctional nephron exhibits a lower glomerular capillary pressure that is induced by an unbalance between afferent and efferent arteriole. Therefore, we tested the hypothesis that oxidative stress induced by CKD differentially impairs the structure or function of efferent vs. afferent arterioles.
METHODS: C57BL/6 mice received sham operations (sham) or 5/6 nephrectomy (RRM) and three months of normal- or high-salt diet or tempol. GFR was assessed from the plasma inulin clearance, arteriolar remodelling from media/lumen area ratio, myogenic responses from changes in luminal diameter with increases in perfusion pressure and passive wall compliance from the wall stress/strain relationships.
RESULTS: Mice with RRM fed a high salt (vs. sham) had a lower GFR (553 ± 25 vs. 758 ± 36 μL min-1  g-1 kidney, P < 0.01) and a larger efferent arteriolar diameter (9.6 ± 0.8 vs. 7.4 ± 0.7 μm, P < 0.05) resulting in a lower media/lumen area ratio (1.4 ± 0.1 vs. 2.4 ± 0.2, P < 0.01). These alterations were corrected by tempol. The myogenic responses of efferent arterioles were about one-half that of afferent arterioles and were unaffected by RRM or salt. Passive wall compliance was reduced by high salt in both afferent and efferent arterioles.
CONCLUSION: A reduction in renal mass with a high-salt diet induces oxidative stress that leads to an outward eutrophic remodelling in efferent arterioles and reduced wall compliance in both afferent and efferent arterioles. This may contribute to the lower GFR in this model of CKD.
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  efferent arteriole; myogenic response; reduced renal mass; vascular remodelling; wall compliance

Mesh:

Substances:

Year:  2016        PMID: 27454938      PMCID: PMC5578453          DOI: 10.1111/apha.12759

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  30 in total

1.  Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability.

Authors:  Mattias Carlström; En Yin Lai; Zufu Ma; Andreas Steege; Andreas Patzak; Ulf J Eriksson; Jon O Lundberg; Christopher S Wilcox; A Erik G Persson
Journal:  Hypertension       Date:  2010-09-27       Impact factor: 10.190

2.  What level of sodium intake worsens renal outcomes?

Authors:  Michael S Lipkowitz; Christopher S Wilcox
Journal:  Am J Hypertens       Date:  2014-05-10       Impact factor: 2.689

3.  Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats.

Authors:  YiLin Ren; Martin A D'Ambrosio; Ruisheng Liu; Patrick J Pagano; Jeffrey L Garvin; Oscar A Carretero
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

4.  Superoxide modulates myogenic contractions of mouse afferent arterioles.

Authors:  En Yin Lai; Anton Wellstein; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2011-08-22       Impact factor: 10.190

5.  Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass.

Authors:  En Yin Lai; Maristela L Onozato; Glenn Solis; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

6.  Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium.

Authors:  E Y Lai; A Patzak; A E G Persson; M Carlström
Journal:  Acta Physiol (Oxf)       Date:  2009-01-12       Impact factor: 6.311

Review 7.  Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation.

Authors:  J E Hall
Journal:  Am J Physiol       Date:  1986-06

8.  Nitric oxide counteracts angiotensin II induced contraction in efferent arterioles in mice.

Authors:  A Patzak; F Kleinmann; E Y Lai; E Kupsch; A Skelweit; R Mrowka
Journal:  Acta Physiol Scand       Date:  2004-08

9.  Renal afferent arteriole in the spontaneously hypertensive rat.

Authors:  V H Gattone; A P Evan; L R Willis; F C Luft
Journal:  Hypertension       Date:  1983 Jan-Feb       Impact factor: 10.190

10.  Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria.

Authors:  M R Weir; D R Dengel; M T Behrens; A P Goldberg
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

View more
  4 in total

1.  NaHCO3 Dilates Mouse Afferent Arteriole Via Na+/HCO3- Cotransporters NBCs.

Authors:  Shan Jiang; Ximing Wang; Jin Wei; Gensheng Zhang; Jie Zhang; Peng Xie; Lan Xu; Lei Wang; Liang Zhao; Lingli Li; Christopher S Wilcox; Jianghua Chen; En Yin Lai; Ruisheng Liu
Journal:  Hypertension       Date:  2019-09-16       Impact factor: 10.190

Review 2.  Salt-induced effects on microvascular function: A critical factor in hypertension mediated organ damage.

Authors:  Maria E Marketou; Spyros Maragkoudakis; Ioannis Anastasiou; Helen Nakou; Marina Plataki; Panos E Vardas; Fragiskos I Parthenakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-19       Impact factor: 3.738

3.  High-Salt Loading Downregulates Nrf2 Expression in a Sodium-Dependent Manner in Renal Collecting Duct Cells.

Authors:  Mi Liu; Mokan Deng; Qimei Luo; Xianrui Dou; Zhanjun Jia
Journal:  Front Physiol       Date:  2020-01-21       Impact factor: 4.566

4.  Fenofibrate improves vascular endothelial function and contractility in diabetic mice.

Authors:  Nan Xu; Qin Wang; Shan Jiang; Qijing Wang; Weipeng Hu; Suhan Zhou; Liang Zhao; Lanyu Xie; Jianghua Chen; Anton Wellstein; En Yin Lai
Journal:  Redox Biol       Date:  2018-10-01       Impact factor: 11.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.